McKelvey, B. A., Guidry, T., Ferris, A. (2026). Use of duration of response as an interpretable endpoint in non-small cell lung cancer drug approvals.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23020